Inventor
LEE CHITASE
US24 patents
⚠️ This page may combine multiple inventors who share the name “LEE CHITASE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REATA PHARMACEUTICALS INC
12 patentsUS9884809B2Feb 6, 2018
Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
REATA PHARMACEUTICALS INC11 citations92
US9174941B2Nov 3, 2015
Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
REATA PHARMACEUTICALS INC22 citations92
US11192852B2Dec 7, 2021
Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
REATA PHARMACEUTICALS INC2 citations72
US11292781B2Apr 5, 2022
Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses
REATA PHARMACEUTICALS INC4 citations70
US12595278B2Apr 7, 2026
Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway
REATA PHARMACEUTICALS INC0 citations62
US11827664B2Nov 28, 2023
Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway
REATA PHARMACEUTICALS INC1 citations62
US11814338B2Nov 14, 2023
Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
REATA PHARMACEUTICALS INC0 citations62
US12545701B2Feb 10, 2026
C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses
REATA PHARMACEUTICALS INC0 citations61
US11584775B2Feb 21, 2023
C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses
REATA PHARMACEUTICALS INC0 citations61
US11059792B2Jul 13, 2021
Imidazolyl tricyclic enones as antioxidant inflammation modulators
REATA PHARMACEUTICALS INC1 citations61
US12195443B2Jan 14, 2025
Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses
REATA PHARMACEUTICALS INC0 citations59
US11993574B2May 28, 2024
Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma
REATA PHARMACEUTICALS INC0 citations50
WARNER LAMBERT CO
10 patentsUS7244763B2Jul 17, 2007
Compounds that modulate PPAR activity and methods of preparation
WARNER LAMBERT CO20 citations82
US7109222B2Sep 19, 2006
Compounds that modulate PPAR activity and methods of preparation
WARNER LAMBERT CO8 citations73
US6867224B2Mar 15, 2005
Compounds that modulate PPAR activity and methods of preparation
WARNER LAMBERT CO6 citations73
US5658902AAug 19, 1997
Quinazolines as inhibitors of endothelin converting enzyme
WARNER LAMBERT CO16 citations70
US6545150B2Apr 8, 2003
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
WARNER LAMBERT CO1 citations60
US6265399B1Jul 24, 2001
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
WARNER LAMBERT CO2 citations60
US6252070B1Jun 26, 2001
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
WARNER LAMBERT CO2 citations60
US5773444AJun 30, 1998
Quinazolines as inhibitors of endothelin converting enzyme
WARNER LAMBERT CO5 citations59
US6440962B2Aug 27, 2002
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
WARNER LAMBERT CO0 citations50
US6833380B2Dec 21, 2004
Compounds that modulate PPAR activity and methods of preparation
WARNER LAMBERT CO1 citations45